{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-029860","form_type":"8-K","ticker":"NKTX","cik":"0001787400","company_name":"Nkarta, Inc.","filed_at":"2023-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.581242+00:00","generated_at":"2026-06-13T17:12:21.312087+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Nkarta to host conference call to discuss updated NKX101 clinical data on June 27","bullets":["Press release on June 26, 2023 announces conference call for June 27, 2023 at 8:00 a.m. ET.","Call to review updated clinical data from ongoing trial of NKX101, an allogeneic CAR NK cell therapy targeting NKG2D ligands.","Company ticker NKTX; slides will be available on Nkarta's website.","Replay of call archived for approximately four weeks."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-029860","json":"https://secwatch.observer/filing/0000950170-23-029860.json","markdown":"https://secwatch.observer/filing/0000950170-23-029860.md","text":"https://secwatch.observer/filing/0000950170-23-029860.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787400/000095017023029860/0000950170-23-029860-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787400/000095017023029860/nktx-20230626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:12:21.312087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}